Not recruitingISRCTN31103960
A dose-finding and proof-of-concept study of the efficacy and safety of MSP-1014.OX in patients with major depressive disorder
Research studyAges 18+United KingdomDepression
Understand this study
Who could participate?
This study is for people with depression. Listed age limits: from 18 years. Other eligibility criteria apply.
- Listed locations
- United Kingdom
What to know before participating
A point to clarify
This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?
Things to check before joining
Study start dateNot clearly listed
- Recruitment status
- Not recruiting
- Enrollment listed in the registry
- Not clearly listed
- Sponsor
- Clerkenwell Health
- Sponsor type
- Unknown or unclear
- Study type
- Other
- Intervention type
- Other / unclear
- Study phase
- Not clearly listed
- Locations
- United Kingdom
- Age range
- Over 18 Years
- Official registry ID
- ISRCTN31103960
- Official title
Show the full official title
A dose-finding and proof-of-concept study of the efficacy and safety of MSP-1014.OX in patients with major depressive disorder
Recruitment & locations
Not recruitingThis badge reflects the study status reported by the registry. Check the registry for the latest information.
United Kingdom
Interested in joining this study?
Questions about this study
Who is behind this study?
The study sponsor is Clerkenwell Health.
Who can participate?
This study is for people with depression. Listed age limits: from 18 years. Other eligibility criteria apply.
Is this study still recruiting?
The registry lists this study as not recruiting.
Want to explore more studies?
Explore studiesRelated studies
Thirty-year follow-up of personality, anxiety and depression after earlier treatment
A before and after study to investigate the effectiveness of an individual psychological intervention in reducing anxiety and depression for heart failure patients
